+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Latin America Infertility (Testing and Treatment) Market 2019-2027

  • ID: 4774251
  • Report
  • Region: Latin America
  • 110 pages
  • Triton Market Research
UP TO OFF
until Jan 31st 2020
1 of 3

FEATURED COMPANIES

  • Andrology Solutions
  • Esco Micro Pte. Ltd.
  • Genea
  • Irvine Scientific
  • Origio
  • Progyny
  • MORE
Market Outlook

This report has determined the infertility (testing and treatment) market in Latin America to proliferate at a CAGR of 7.27% during the forecast years (2019-2027).

Mexico, Brazil and countries in rest of Latin America together form the infertility (testing and treatment) market in Latin America. The Latin America infertility (testing and treatment) market has shown significant growth over the years, which could be attributed to a variety of factors such as the rise in infertility and treatment awareness and the advancements in healthcare, which have given rise to a plethora of options.

Fertility and surgical centers are major end-users of the infertility (testing and treatment) market. They assist individuals in conceiving. Such medical clinics apply a variety of diagnosis tests as well as advanced medical treatments such as fertility tests, fertility treatments, sperm retrieval, genetic & infection screening, testicular ultrasound scanning, etc., to achieve conception artificially and medically to individuals. In-vitro fertilization is popular assisted reproductive technology procedure which is performed at fertility and surgical centers. Rising infertility among individuals and troubles during conception among women in the late 30s and early 40s age group majorly contributes to the growth of the fertility and surgical centers during the forecast period.

Latest technologies enable doctors to retrieve eggs more safely and effectively. Improvement has been made through invasive part of the IVF cycle in egg retrieval. Egg retrieval in IVF involves surgical treatment. Mature eggs are removed from egg follicles in the ovary and are then fertilized in the laboratory. With improvements in technology, egg retrieval, which was done through laparoscopy, is now performed transvaginally with ultrasound.

Embryo-freezing technology has led to better quality embryos for fertilization. In the case where pregnancy is not achieved, the frozen embryos can be used for future cycles without extra expense. Frozen embryo transfer (FET) technology is less costly than new IVF procedures. Access to treatments has also increased over the years. Apart from the advancements in infertility treatments, patient care has also improved a lot. Various hospitals and clinics take proper care of the couples throughout the procedure. These advances in healthcare have fine-tuned the fertility treatment, thus enabling market growth.

Competitive Outlook

Genea, Quest Diagnostic, Andrology Solutions, The Cooper Companies, Inc., Progyny, Thermo Fisher Scientific, Inc., Vitrolife AB, Halotech DNA, Origio, Esco Micro Pte. Ltd., Ovascience, Merck, Endo Pharmaceuticals, Irvine Scientific and Ferring Pharmaceuticals are few of the notable companies operating in the market.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Andrology Solutions
  • Esco Micro Pte. Ltd.
  • Genea
  • Irvine Scientific
  • Origio
  • Progyny
  • MORE
1. Infertility (Testing And Treatment) Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Key Insights
2.2.1. Ivf Dominates the Female Treatment Market
2.2.2. Oxidative Stress Analysis is the Fastest Growing Male Infertility Testing Market
2.3. Porter’s Five Force Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute
2.3.3. Bargaining Power of Buyers
2.3.4. Bargaining Power of Suppliers
2.3.5. Intensity of Competitive Rivalry
2.4. Key Impact Analysis
2.4.1. Treatment Options
2.4.2. Quality of Medical Procedures
2.4.3. Price of Treatments
2.4.4. Shift Towards Medical Tourism
2.4.5. Reimbursement
2.5. Market Attractiveness Index
2.6. Vendor Scorecard
2.7. Industry Components
2.7.1. Raw Material Procurement
2.7.2. Manufacturing
2.7.3. Supply LoGIStics
2.7.4. Distribution Channels
2.7.5. End-Users
2.8. Regulatory Framework
2.9. Market Drivers
2.9.1. Rise in Infertility And Treatment Awareness
2.9.2. Medical Tourism in Fertility Treatments
2.9.3. Surrogacy Laws Are Getting More Defined
2.9.4. Healthcare Advances Have Fine-Tuned Fertility Treatment
2.9.5. Increasing Effectiveness of Treatments
2.9.6. Healthier Donor Eggs
2.9.7. Introduction of New Testing Devices
2.10. Market Restraints
2.10.1. Treatment Procedure Out of Reach For Many Due to High Costs
2.10.2. Country-Wise Regulatory Issues
2.11. Market Opportunities
2.11.1. Reducing the Cost of Treatment to Make It More Accessible
2.11.2. Ivf Attracting Investments From Private Equity Investors
2.11.3. Diy Testing Increasing Access And Reducing Cost
2.12. Market Challenges
2.12.1. Infertility Considered a Social Taboo Amongst Men
2.12.2. Perils of Multiple Pregnancies
2.12.3. Traditional Treatments Used Widely As An Alternative For Infertility Treatments

3. Infertility (Testing And Treatment) Market Outlook - By Gender
3.1. Male Gender
3.1.1. Testing
3.1.1.1. Dna Fragmentation
3.1.1.2. Oxidative Stress Analysis
3.1.1.3. Sperm Penetration Assay
3.1.1.4. Computer-Assisted Semen Analysis (Casa)
3.1.1.5. Sperm Agglutination
3.1.1.6. Microscopic Examination
3.1.1.7. Others
3.1.2. Treatment
3.1.2.1. Vasovasostomy And Vasoepididymostomy (Vasectomy Reversal)
3.1.2.2. Sperm Retrieval Treatment
3.1.2.3. Microsurgical Sperm Aspiration (Mesa)
3.1.2.4. Testicular Sperm Extraction (Tese)
3.1.2.5. Varicocele Repairs
3.1.2.6. Assisted Reproductive Techniques (Art)
3.1.2.7. Intrauterine Insemination (Iui)
3.1.2.8. In-Vitro Fertilization (Ivf)
3.1.2.9. Intracytoplasmic Sperm Injection (Icsi)
3.2. Female Gender
3.2.1. Female Infertility Testing
3.2.1.1. Ovulation Testing
3.2.1.2. Hysterosalpingography
3.2.1.3. Laparoscopy
3.2.1.4. Transvaginal Ultrasound
3.2.1.5. Ovarian Reserve Testing
3.2.1.6. Hormonal Level Testing
3.2.1.7. Others
3.2.2. Treatment
3.2.2.1. In-Vitro Fertilization
3.2.2.2. Intrauterine Insemination (Iui)
3.2.2.3. Drug And Hormone Therapies

4. Infertility (Testing And Treatment) Market Outlook - By End-Use
4.1. Fertility Clinics
4.2. Hospitals
4.3. Surgical Centers
4.4. Clinical Research Institutes

5. Infertility (Testing And Treatment) Market - Regional Outlook
5.1. Latin America
5.1.1. Country Analysis
5.1.1.1. Brazil
5.1.1.2. Mexico
5.1.1.3. Rest of Latin America

6. Competitive Landscape
6.1. Andrology Solutions
6.2. Endo Pharmaceuticals
6.3. Progyny
6.4. Ferring Pharmaceuticals
6.5. Genea
6.6. Halotech Dna
6.7. Irvine Scientific
6.8. Merck
6.9. Origio
6.10. Ovascience
6.11. Vitrolife Ab
6.12. Thermo Fisher Scientific, Inc.
6.13. the Cooper Companies, Inc.
6.14. Quest Diagnostic
6.15. Esco Micro Pte. Ltd.

7. Research Methodology & Scope
7.1. Research Scope & Deliverables
7.1.1. Objectives of Study
7.2. Sources of Data
7.2.1. Primary Data Sources
7.2.2. Secondary Data Sources
7.3. Research Methodology
7.3.1. Evaluation of Proposed Market
7.3.2. Identification of Data Sources
7.3.3. Assessment of Market Determinants
7.3.4. Data Collection
7.3.5. Data Validation & Analysis

List of Tables
Table 1: Latin America Infertility (Testing And Treatment) Market, By Country, 2019-2027 (In $ Million)
Table 2: Market Attractiveness Index
Table 3: Vendor Scorecard
Table 4: Regulatory Framework
Table 5: Average Cost Comparison of Infertility Treatments
Table 6: Latin America Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Table 7: Latin America Infertility (Testing And Treatment) Market, By Gender, 2019-2027 (In $ Million)
Table 8: Latin America Infertility (Testing And Treatment) Market, By Male Gender, 2019-2027 (In $ Million)
Table 9: Latin America Infertility (Testing And Treatment) Market, By Male Infertility Testing, 2019-2027 (In $ Million)
Table 10: Latin America Infertility (Testing And Treatment) Market, By Female Gender, 2019-2027 (In $ Million)
Table 11: Latin America Infertility (Testing And Treatment) Market, By Female Infertility Testing, 2019-2027 (In $ Million)
Table 12: Latin America Infertility (Testing And Treatment) Market, By End-Use, 2019-2027 (In $ Million)

List of Figures
Figure 1: Latin America Infertility (Testing And Treatment) Market, By End-User, 2018 & 2027 (In %)
Figure 2: Porter’s Five Force Analysis
Figure 3: Key Buying Impact Analysis
Figure 4: Industry Components
Figure 5: Major Fertility Treatment Destination Ranking
Figure 6: Clinical Algorithm For the Evaluation of Infertile Woman
Figure 7: Rate of Multiple Deliveries
Figure 8: Latin America Infertility (Testing And Treatment) Market, By Male Gender, 2019-2027 (In $ Million)
Figure 9: Latin America Infertility (Testing And Treatment) Market, By Testing, 2019-2027 (In $ Million)
Figure 10: Latin America Infertility (Testing And Treatment) Market, By Dna Fragmentation, 2019-2027 (In $ Million)
Figure 11: Causes of Sperm Dna Fragmentation
Figure 12: Latin America Infertility (Testing And Treatment) Market, By Oxidative Stress Analysis, 2019-2027 (In $ Million)
Figure 13: Latin America Infertility (Testing And Treatment) Market, By Sperm Penetration Assay, 2019-2027 (In $ Million)
Figure 14: Latin America Infertility (Testing And Treatment) Market, By Computer-Assisted Semen Analysis, 2019-2027 (In $ Million)
Figure 15: Latin America Infertility (Testing And Treatment) Market, By Sperm Agglutination, 2019-2027 (In $ Million)
Figure 16: Latin America Infertility (Testing And Treatment) Market, By Microscopic Examination, 2019-2027 (In $ Million)
Figure 17: Latin America Infertility (Testing And Treatment) Market, By Others, 2019-2027 (In $ Million)
Figure 18: Latin America Infertility (Testing And Treatment) Market, By Treatment, 2019-2027 (In $ Million)
Figure 19: Latin America Infertility (Testing And Treatment) Market, By Female Gender, 2019-2027 (In $ Million)
Figure 20: Latin America Infertility (Testing And Treatment) Market, By Female Infertility Testing, 2019-2027 (In $ Million)
Figure 21: Latin America Infertility (Testing And Treatment) Market, By Ovulation Testing, 2019-2027 (In $ Million)
Figure 22: Latin America Infertility (Testing And Treatment) Market, By Hysterosalpingography, 2019-2027 (In $ Million)
Figure 23: Latin America Infertility (Testing And Treatment) Market, By Laparoscopy, 2019-2027 (In $ Million)
Figure 24: Latin America Infertility (Testing And Treatment) Market, By Transvaginal Ultrasound, 2019-2027 (In $ Million)
Figure 25: Latin America Infertility (Testing And Treatment) Market, By Ovarian Reserve Testing, 2019-2027 (In $ Million)
Figure 26: Latin America Infertility (Testing And Treatment) Market, By Hormonal Level Testing, 2019-2027 (In $ Million)
Figure 27: Latin America Infertility (Testing And Treatment) Market, By Others, 2019-2027 (In $ Million)
Figure 28: Latin America Infertility (Testing And Treatment) Market, By Female Infertility Treatment, 2019-2027 (In $ Million)
Figure 29: Latin America Infertility (Testing And Treatment) Market, By Fertility Clinics, 2019-2027 (In $ Million)
Figure 30: Latin America Infertility (Testing And Treatment) Market, By Hospitals, 2019-2027 (In $ Million)
Figure 31: Latin America Infertility (Testing And Treatment) Market, By Surgical Centers, 2019-2027 (In $ Million)
Figure 32: Latin America Infertility (Testing And Treatment) Market, By Clinical Research Institutes, 2019-2027 (In $ Million)
Figure 33: Latin America Infertility (Testing And Treatment) Market, Regional Outlook, 2018 & 2027 (In %)
Figure 34: Brazil Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 35: Mexico Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Figure 36: Rest of Latin America Infertility (Testing And Treatment) Market, 2019-2027 (In $ Million)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Andrology Solutions
  • Endo Pharmaceuticals
  • Progyny
  • Ferring Pharmaceuticals
  • Genea
  • Halotech Dna
  • Irvine Scientific
  • Merck
  • Origio
  • Ovascience
  • Vitrolife AB
  • Thermo Fisher Scientific, Inc.
  • The Cooper Companies, Inc.
  • Quest Diagnostic
  • Esco Micro Pte. Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll